A standardised extract of Echinacea purpurea is an efficient and cost-effective antiviral counter measure to vaccination in the prevention of respiratory tract infections (RTIs) and for reducing concomitant viral loads, say scientists.
Despite the presence of established ingredients, an expanding consumer pool and constant demand for immune health products is offering opportunities for new ingredients to break through and offer formulators different ways to support immunity.
A recent review paper that summarizes what’s known about the antiviral effects of various botanical ingredients has generated keen interest among researchers, according to one of the authors.
Could 2021 be THE worst year in memory for botanical supply?
As sales of dietary supplements and natural products remain high – and many companies report record sales – the strain on the supply chain is immense, and for botanicals in particular, and that means a difficult 2021 could be on the horizon.
It’s not just immune support products that are selling well for dietary supplement firms, with consumers also seeking our adaptogens and products to help manage the stress of living through a pandemic, says the CEO of Herbalist & Alchemist.
Many dietary supplement companies are experiencing surging sales as consumers seek out health-promoting products, and Chicago-based NOW is no different. The company experienced “incredible” sales in March, but ingredient supply bottlenecks and the economic...
A commercial Echinacea angustifolia root extract may help decrease anxiety in adults, suggests a new gold standard double‐blind, placebo-controlled trial.
With the cold season well and truly upon us, it seems that Brits
are turning to herbal remedies in a bid to stave off the sniffles.
Both Boots and the National Association of Healthfood Stores this
week reported an increase in sales...
Echinacea's reputation for chasing off the common cold has made it
one of the most widely used herbal products on the market, but a
study published today casts doubt on its efficacy. Jess
Halliday discusses the merits and shortfalls...
Canadian company Natural Factors believes it has set a new
benchmark in the research and testing of its echinacea-based
product, Echinamide, Philippa Nuttall reports.
Echinacea supplements, one of the most popular herbal remedies in
the US, which is taken to treat the common cold, do not meet
quality standards according to researchers whose findings prove how
dietary supplements differ in their...
A syrup made with the popular herb echinacea reduced the number of
respiratory tract infections in children but did not reduce the
severity or duration of infections, report authors of a new
clinical trial in today's Journal...
Echinacea, currently one of the most popular herbal remedies in
Europe, taken to treat the common cold, had no effect when tested
on a small group of students with colds, report researchers in the
US.
